{"id":"https://openalex.org/W7225411707","doi":"https://doi.org/10.1002/cpt.70541","title":"Impact of Food and Beverage on Enlicitide Pharmacokinetics and LDL \u2010C Lowering","display_name":"Impact of Food and Beverage on Enlicitide Pharmacokinetics and LDL \u2010C Lowering","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225411707","doi":"https://doi.org/10.1002/cpt.70541","pmid":"https://pubmed.ncbi.nlm.nih.gov/42995140","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13743531"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.70541","doi":"https://doi.org/10.1002/cpt.70541","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70541","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70541","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70541","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073513179","display_name":"Douglas G. Johns","orcid":"https://orcid.org/0000-0002-8726-8514","observed_orcids":["https://orcid.org/0000-0002-8726-8514"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas G. Johns","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116310717","display_name":"Maja Skataric","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maja Skataric","raw_affiliation_strings":["Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021548524","display_name":"Susan Zhou","orcid":"https://orcid.org/0000-0003-3481-6270","observed_orcids":["https://orcid.org/0000-0003-3481-6270"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Zhou","raw_affiliation_strings":["Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038239466","display_name":"Ferdous Gheyas","orcid":"https://orcid.org/0009-0006-5114-3572","observed_orcids":["https://orcid.org/0009-0006-5114-3572"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ferdous Gheyas","raw_affiliation_strings":["Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063567246","display_name":"Ednan K. Bajwa","orcid":"https://orcid.org/0000-0001-9026-1009","observed_orcids":["https://orcid.org/0000-0001-9026-1009"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ednan Bajwa","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072623076","display_name":"Puja Banka","orcid":"https://orcid.org/0000-0002-1407-2705","observed_orcids":["https://orcid.org/0000-0002-1407-2705"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puja Banka","raw_affiliation_strings":["Global Clinical Development Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015685483","display_name":"Filippos Kesisoglou","orcid":"https://orcid.org/0000-0002-2805-0662","observed_orcids":["https://orcid.org/0000-0002-2805-0662"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Filippos Kesisoglou","raw_affiliation_strings":["Pharmaceutical Sciences and Clinical Supply Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences and Clinical Supply Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032795065","display_name":"Allen Hunt","orcid":"https://orcid.org/0000-0002-3945-7070","observed_orcids":["https://orcid.org/0000-0002-3945-7070"]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Hunt","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130791713","display_name":"David Bruce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Bruce","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161010701","display_name":"Corey Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Anderson","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048378439","display_name":"Helen Manthos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Manthos","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006831055","display_name":"Jonathan D. Pollock","orcid":"https://orcid.org/0000-0002-7635-8100","observed_orcids":["https://orcid.org/0000-0002-7635-8100"]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Pollock","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075134303","display_name":"Paul J Donabella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Donabella","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050774473","display_name":"Campbell Thompson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103107","display_name":"Celerion (United States)","ror":"https://ror.org/01gtvsc36","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Campbell Thompson","raw_affiliation_strings":["Celerion, Inc.  Lincoln Nebraska USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celerion, Inc.  Lincoln Nebraska USA","institution_ids":["https://openalex.org/I4210103107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161060241","display_name":"Daniel Freire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Freire","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130733800","display_name":"Kiet Giang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kiet Giang","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036018611","display_name":"Frank Pietrantonio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Pietrantonio","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045831371","display_name":"Dennis G. Wolford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis Wolford","raw_affiliation_strings":["Translational Medicine Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068645876","display_name":"Piyali Basak","orcid":"https://orcid.org/0000-0002-0173-3543","observed_orcids":["https://orcid.org/0000-0002-0173-3543"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Piyali Basak","raw_affiliation_strings":["Biostatistics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043549024","display_name":"Maxwell Pistilli","orcid":"https://orcid.org/0000-0002-4266-4150","observed_orcids":["https://orcid.org/0000-0002-4266-4150"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maxwell Pistilli","raw_affiliation_strings":["Biostatistics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":"https://orcid.org/0000-0002-4266-4150","affiliations":[{"raw_affiliation_string":"Biostatistics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016298192","display_name":"Bhavna S. Kantesaria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhavna Kantesaria","raw_affiliation_strings":["Pharmacokinetics, Dynamics, Metabolism and Bioanalytics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics, Metabolism and Bioanalytics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079794570","display_name":"Prajakti A. Kothare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prajakti Kothare","raw_affiliation_strings":["Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077984843","display_name":"Islam Rasem Younis","orcid":"https://orcid.org/0000-0001-9000-0431","observed_orcids":["https://orcid.org/0000-0001-9000-0431"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Islam R. Younis","raw_affiliation_strings":["Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA"],"raw_orcid":"https://orcid.org/0000-0001-9000-0431","affiliations":[{"raw_affiliation_string":"Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway New Jersey USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5077984843"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":{"value":4410,"currency":"USD","value_usd":4410},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8148999810218811,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.06270000338554382,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/food-drug-interactions","display_name":"food-drug interactions","score":0.5529999732971191},{"id":"https://openalex.org/keywords/high-fat-meal","display_name":"high-fat meal","score":0.6919999718666077},{"id":"https://openalex.org/keywords/fasting-duration","display_name":"fasting duration","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-absorption","display_name":"drug absorption","score":0.47999998927116394},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7519999742507935},{"id":"https://openalex.org/keywords/exposure-response-model","display_name":"exposure-response modeling","score":0.671999990940094},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.7540000081062317},{"id":"https://openalex.org/keywords/dosing-instructions","display_name":"dosing instructions","score":0.703000009059906},{"id":"https://openalex.org/keywords/missed-doses","display_name":"missed doses","score":0.6629999876022339},{"id":"https://openalex.org/keywords/coffee-and-tea","display_name":"coffee and tea","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8564000129699707},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8382999897003174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7081999778747559},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5580000281333923},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.5539000034332275},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.51419997215271},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4984000027179718},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4165000021457672},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.41359999775886536},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.3716000020503998},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.36660000681877136},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.36309999227523804},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.32100000977516174},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.31540000438690186},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30559998750686646},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.2870999872684479},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2766000032424927},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.27649998664855957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26510000228881836},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.25839999318122864},{"id":"https://openalex.org/C3019451088","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Patient compliance","level":2,"score":0.25099998712539673}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.70541","doi":"https://doi.org/10.1002/cpt.70541","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70541","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70541","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:42995140","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42995140","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13743531","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13743531/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cpt.70541","doi":"https://doi.org/10.1002/cpt.70541","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70541","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70541","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225411707.pdf","grobid_xml":"https://content.openalex.org/works/W7225411707.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W47093099","https://openalex.org/W2003556240","https://openalex.org/W2021797926","https://openalex.org/W2151717066","https://openalex.org/W2164089346","https://openalex.org/W2801075353","https://openalex.org/W2801578251","https://openalex.org/W2901306081","https://openalex.org/W2996204986","https://openalex.org/W3039048191","https://openalex.org/W3133183229","https://openalex.org/W3137006723","https://openalex.org/W3164680927","https://openalex.org/W4367602059","https://openalex.org/W4386194106","https://openalex.org/W4406475329","https://openalex.org/W4408719903","https://openalex.org/W4410344378","https://openalex.org/W4411533283","https://openalex.org/W4414444246","https://openalex.org/W4414487033","https://openalex.org/W4416054854","https://openalex.org/W4417159173","https://openalex.org/W7117238826","https://openalex.org/W7127574708","https://openalex.org/W7140160949","https://openalex.org/W7143369042","https://openalex.org/W7162108450","https://openalex.org/W7162526287","https://openalex.org/W7163390637","https://openalex.org/W7166571871","https://openalex.org/W7167052890","https://openalex.org/W7212058658"],"related_works":["https://openalex.org/W7212058658","https://openalex.org/W7212033536","https://openalex.org/W7221765207","https://openalex.org/W7164171533","https://openalex.org/W7127574708","https://openalex.org/W2003302671","https://openalex.org/W3212843287","https://openalex.org/W7133675311","https://openalex.org/W4417137270","https://openalex.org/W2012127622"],"abstract_inverted_index":{"Enlicitide":[0,82],"decanoate":[1],"is":[2,186],"a":[3,77,106,184,199],"macrocyclic":[4],"peptide":[5],"first-in-class":[6],"oral":[7],"PCSK9":[8],"inhibitor":[9],"that":[10,241],"lowers":[11],"LDL-C,":[12],"with":[13,122,165,180,190,256],"maximal":[14],"efficacy":[15],"achieved":[16],"when":[17,177],"administered":[18,179],"on":[19,48,55,73,154,259],"an":[20,111],"empty":[21],"stomach.":[22],"This":[23],"work":[24],"characterizes":[25],"the":[26,53,68,205,224,234,245],"effects":[27,69],"of":[28,70,101,168,238],"food,":[29],"pre-dose":[30,133],"fasting":[31,134],"duration":[32,135],"(2-8":[33],"hours),":[34],"water":[35],"volume,":[36,144],"common":[37],"beverages":[38],"(black":[39],"coffee":[40,146,192],"and":[41,44,51,85,97,118,196,208],"plain":[42,148,194],"tea),":[43],"other":[45],"real-world":[46],"scenarios":[47],"enlicitide":[49,74,102,155,225],"exposure":[50,75,84],"predicts":[52],"impact":[54,258],"clinical":[56,228],"efficacy.":[57,260],"Three":[58],"phase":[59,226],"I,":[60],"open-label,":[61],"crossover":[62],"studies":[63],"in":[64,110,115,223,251],"healthy":[65],"participants":[66],"evaluated":[67],"these":[71,231],"conditions":[72,91,124],"following":[76,198],"single":[78],"20":[79],"mg":[80],"dose.":[81],"steady-state":[83,116],"corresponding":[86],"LDL-C":[87,158,166,219],"reductions":[88,159,167],"under":[89,171],"various":[90,163],"were":[92],"predicted":[93],"using":[94],"population":[95],"pharmacokinetic":[96,235],"exposure-response":[98],"models.":[99],"Administration":[100],"30":[103],"minutes":[104],"after":[105],"high-fat":[107],"meal":[108],"resulted":[109],"approximately":[112,169],"48%":[113],"reduction":[114],"AUC":[117],"delayed":[119],"absorption":[120],"compared":[121],"fasted":[123,172],"(median":[125],"Tmax":[126],"~8":[127],"hours":[128,140],"vs.":[129],"0.5-1":[130],"hour).":[131],"Increasing":[132],"from":[136,244],"2":[137],"to":[138,175,216],"8":[139],"increased":[141],"exposure.":[142,156],"Water":[143],"black":[145,191],"or":[147,182,193,248],"tea":[149],"had":[150],"no":[151],"meaningful":[152],"effect":[153],"Model-predicted":[157],"remained":[160],"robust":[161],"across":[162],"conditions,":[164,173],"64%":[170],"62%":[174],"63%":[176],"occasionally":[178,187],"food":[181],"if":[183],"dose":[185],"missed,":[188],"60%":[189],"tea,":[195],"59%":[197],"4-hour":[200],"fast.":[201],"These":[202],"data":[203],"support":[204],"recommended":[206,246],"dosing":[207,247],"administration":[209],"instructions":[210],"for":[211],"enlicitide,":[212,239],"which":[213],"are":[214],"expected":[215],"provide":[217],"~60%":[218],"reduction,":[220],"as":[221],"seen":[222],"III":[227],"trials.":[229],"Furthermore,":[230],"findings":[232],"highlight":[233],"forgiveness":[236],"potential":[237],"suggesting":[240],"occasional":[242],"departures":[243],"sporadic":[249],"lapses":[250],"compliance":[252],"may":[253],"be":[254],"tolerated":[255],"minimal":[257]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-07T00:00:00"}